Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nathan Gunn"'
Publikováno v:
Journal of Oncology Practice. 7:76-79
Off-label prescribing in oncology is common and unregulated. The aim of this study was to describe the off-label use of rituximab, a novel anti-CD20 antibody, among patients from a large proprietary insurance database to understand how frequently and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b72bf919fa22281038ccb98746a997
https://doi.org/10.1200/jop.2010.000042
https://doi.org/10.1200/jop.2010.000042
Publikováno v:
JAMA. 284:178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4d2b839d6792354f612f85891e4b75
https://doi.org/10.1001/jama.284.2.175
https://doi.org/10.1001/jama.284.2.175
Autor:
Nathan Gunn, Willis H. Navarro, Curt A. Ries, Thomas G. Martin, Charles A. Linker, Paul D. Varosy, Lloyd E. Damon
Publikováno v:
Biology of Blood and Marrow Transplantation. (10):643-648
We studied platelet engraftment in 58 patients with acute myeloid leukemia in first remission treated with autologous stem cell transplantation (ASCT) to determine whether CD34+ cell doses10 x 10(6)/kg were associated with faster platelet engraftment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ae397d150bbd5e77a3a9bb645cad7b